Fulcrum Therapeutics Inc (FULC) — Financial Flexibility Index
Fulcrum Therapeutics Inc (FULC) has a Financial Flexibility Index of -0.85x as of September 2025. Free cash flow of $-14.10 Million (operating CF $-14.19 Million minus capex $90.00K) represents -1% of total liabilities ($16.49 Million). Also explore FULC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fulcrum Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Fulcrum Therapeutics Inc across 8 annual periods. Check FULC PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Fulcrum Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Fulcrum Therapeutics Inc. For the full company profile including market capitalisation, see FULC company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.11x | $-1.94 Million | $-2.22 Million | $17.68 Million | ▲ +97.3% |
| 2023 | -4.02x | $-90.46 Million | $-90.97 Million | $22.50 Million | ▼ -17.3% |
| 2022 | -3.43x | $-95.09 Million | $-97.05 Million | $27.74 Million | ▼ -4.7% |
| 2021 | -3.27x | $-76.77 Million | $-78.48 Million | $23.46 Million | ▼ -115.1% |
| 2020 | -1.52x | $-52.31 Million | $-53.66 Million | $34.40 Million | ▲ +8.3% |
| 2019 | -1.66x | $-38.63 Million | $-39.48 Million | $23.29 Million | ▼ -19.4% |
| 2018 | -1.39x | $-13.58 Million | $-22.56 Million | $9.77 Million | ▲ +76.9% |
| 2017 | -6.02x | $-18.17 Million | $-20.07 Million | $3.02 Million | — |